WuXi Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax

We are excited to announce the opening of a representative office in the Tel Aviv area of Israel, one of the most dynamic healthcare innovation ecosystems in the world.  This new office will promote WuXi’s broad platform of integrated R&D services to local customers.  It will also collaborate with Pontifax, a leading healthcare-dedicated venture capital firm based in Israel, to invest in promising technologies in Israel, particularly those that can potentially advance WuXi’s capabilities.

Our presence in Israel enables us to work closely with Pontifax to help many of their portfolio companies and other start-up companies in Israel’s biotech industry.  According to a recent article on Nature Reviews Drug Discovery, China, Israel and Korea are expected to become world future innovators for pharmaceutical R&D in emerging markets. This step advances WuXi’s mission of helping entrepreneurs in the global life science industry to realize their dreams of developing innovative products to benefit the world’s patients.

Please enjoy the press release: http://www.wuxiapptec.com/press/detail/249/18.html, and let us know if you have any questions or inquiries.

Related links:

Foundation Medicine and WuXi Collaborate to Offer Best-in-Class Comprehensive Genomic Profiling in China
Targos and WuXi Collaborate on Clinical Biomarker Services and Pathology Training in China